N4 Pharma PLC (N4P) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.251x

Based on the latest financial reports, N4 Pharma PLC (N4P) has a cash flow conversion efficiency ratio of -0.251x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-444.37K ≈ $-54.07 USD) by net assets (GBX1.77 Million ≈ $215.03 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

N4 Pharma PLC - Cash Flow Conversion Efficiency Trend (1991–2024)

This chart illustrates how N4 Pharma PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read N4 Pharma PLC total liabilities for a breakdown of total debt and financial obligations.

N4 Pharma PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of N4 Pharma PLC ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Norman Broadbent Plc
LSE:NBB
0.147x
Catenai PLC
LSE:CTAI
-0.188x
Coro Energy PLC
LSE:CORO
-0.278x
Tiger Royalties and investments Plc
LSE:TIR
-0.272x
Bangkok Bank Public Company Limited
F:BKKF
0.014x
FANDIFI TECHNOLOGY CORP.
F:TQ4
N/A
Fitness Champs Holdings Limited Common Stock
NASDAQ:FCHL
3.759x
Novae Group Plc
STU:NVAL
0.080x

Annual Cash Flow Conversion Efficiency for N4 Pharma PLC (1991–2024)

The table below shows the annual cash flow conversion efficiency of N4 Pharma PLC from 1991 to 2024. For the full company profile with market capitalisation and key ratios, see how much is N4 Pharma PLC worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 GBX651.40K
≈ $79.26
GBX-971.50K
≈ $-118.20
-1.491x -47.23%
2023-12-31 GBX1.19 Million
≈ $145.23
GBX-1.21 Million
≈ $-147.11
-1.013x -155.38%
2022-12-31 GBX2.09 Million
≈ $254.07
GBX-828.26K
≈ $-100.78
-0.397x +52.34%
2021-12-31 GBX2.13 Million
≈ $259.12
GBX-1.77 Million
≈ $-215.63
-0.832x -120.69%
2020-12-31 GBX3.66 Million
≈ $444.99
GBX-1.38 Million
≈ $-167.79
-0.377x +53.81%
2019-12-31 GBX987.34K
≈ $120.13
GBX-806.00K
≈ $-98.07
-0.816x +46.56%
2018-12-31 GBX879.94K
≈ $107.06
GBX-1.34 Million
≈ $-163.56
-1.528x -105.62%
2017-12-31 GBX1.28 Million
≈ $155.71
GBX-950.80K
≈ $-115.68
-0.743x -105.70%
2016-12-31 GBX1.04 Million
≈ $126.66
GBX-376.00K
≈ $-45.75
-0.361x +73.14%
2015-12-31 GBX641.00K
≈ $77.99
GBX-862.00K
≈ $-104.88
-1.345x -312.13%
2014-12-31 GBX1.04 Million
≈ $126.78
GBX-340.00K
≈ $-41.37
-0.326x -1194.68%
2013-12-31 GBX3.45 Million
≈ $420.01
GBX-87.00K
≈ $-10.59
-0.025x +71.96%
2012-12-31 GBX3.60 Million
≈ $438.62
GBX-324.00K
≈ $-39.42
-0.090x -131.49%
2011-12-31 GBX3.49 Million
≈ $424.63
GBX996.00K
≈ $121.18
0.285x +238.91%
2010-12-31 GBX2.96 Million
≈ $359.78
GBX249.00K
≈ $30.30
0.084x -70.70%
2009-12-31 GBX2.63 Million
≈ $319.63
GBX755.00K
≈ $91.86
0.287x +323.05%
2008-12-31 GBX1.43 Million
≈ $173.75
GBX-184.00K
≈ $-22.39
-0.129x -194.06%
2007-12-31 GBX1.17 Million
≈ $142.11
GBX160.00K
≈ $19.47
0.137x +284.62%
2006-12-31 GBX903.00K
≈ $109.87
GBX-67.00K
≈ $-8.15
-0.074x +74.52%
2005-12-31 GBX388.00K
≈ $47.21
GBX-113.00K
≈ $-13.75
-0.291x -273.91%
2004-12-31 GBX836.00K
≈ $101.72
GBX140.00K
≈ $17.03
0.167x +255.45%
2003-12-31 GBX-789.00K
≈ $-96.00
GBX85.00K
≈ $10.34
-0.108x -113.63%
2002-12-31 GBX-935.00K
≈ $-113.76
GBX-739.00K
≈ $-89.91
0.790x +539.60%
2001-12-31 GBX-1.17 Million
≈ $-142.11
GBX210.00K
≈ $25.55
-0.180x -288.74%
2000-12-31 GBX-3.99 Million
≈ $-485.35
GBX-380.00K
≈ $-46.24
0.095x +76.88%
1999-12-31 GBX-3.17 Million
≈ $-386.31
GBX-171.00K
≈ $-20.81
0.054x -94.55%
1998-12-31 GBX-2.76 Million
≈ $-335.57
GBX-2.72 Million
≈ $-331.43
0.988x +138.27%
1997-12-31 GBX1.03 Million
≈ $125.32
GBX-2.66 Million
≈ $-323.40
-2.581x -1497.58%
1996-12-31 GBX10.93 Million
≈ $1.33K
GBX2.02 Million
≈ $245.53
0.185x +1283.15%
1995-12-31 GBX12.21 Million
≈ $1.49K
GBX163.00K
≈ $19.83
0.013x -95.81%
1994-12-31 GBX10.48 Million
≈ $1.27K
GBX3.34 Million
≈ $405.89
0.318x +748.91%
1993-12-31 GBX8.26 Million
≈ $1.01K
GBX310.00K
≈ $37.72
0.038x -90.31%
1992-12-31 GBX7.03 Million
≈ $855.47
GBX2.72 Million
≈ $331.19
0.387x +249.12%
1991-12-31 GBX9.33 Million
≈ $1.14K
GBX-2.42 Million
≈ $-294.69
-0.260x --

About N4 Pharma PLC

LSE:N4P UK Drug Manufacturers - Specialty & Generic
Market Cap
$48.10K
GBX395.33 Million GBX
Market Cap Rank
#31125 Global
#1204 in UK
Share Price
GBX0.48
Change (1 day)
+0.00%
52-Week Range
GBX0.38 - GBX0.73
All Time High
GBX32.90
About

N4 Pharma Plc, a specialist pharmaceutical company, develops nanoparticle silica delivery systems to enhance the cellular delivery and potency of cancer treatments and vaccines in the United Kingdom. It develops Nuvec, a silica nanoparticle delivery system, which has an irregular surface structure that traps and protects siRNA/RNA/DNA; and Liptide, a platform to deliver a proprietary siRNA sequen… Read more